Search research articles
Contact Us
Filters
Showing results (461-470 of 483) with videos related to
Page
of 49
Sort By:
Human Pathology
|
March 13, 1998
Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers
A Rhoton-Vlasak, J M Wagner, J L Rutgers, et al.
Clinical Genetics
|
March 23, 2004
Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers
M Christiansen, S O Larsen, C Oxvig, et al.
The American Review of Respiratory Disease
|
December 1, 1991
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators
J B Sedgwick, W J Calhoun, G J Gleich, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis
K Yamazaki, K Suzuki, A Nakamura, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 1, 1996
Cytokine production at the site of disease in chronic eosinophilic pneumonitis
H Kita, S Sur, L W Hunt, et al.
Allergy
|
November 1, 1995
Allergen challenge in asthma: association of eosinophils and lymphocytes with interleukin-5
S Sur, G J Gleich, K P Offord, et al.
The American Review of Respiratory Disease
|
March 1, 1993
Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation
D S Collins, R Dupuis, G J Gleich, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 2, 1998
Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation
D Stelts, R W Egan, A Falcone, et al.
The Journal of Allergy and Clinical Immunology
|
September 13, 2000
Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected
H Kita, R K Jorgensen, C E Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration
J A Sosman, K Bartemes, K P Offord, et al.
Page
of 49
Search research articles
Search
Showing results (461-470 of 483) with videos related to
Sort By:
Page
of 49
Human Pathology
|
March 13, 1998
Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers
A Rhoton-Vlasak, J M Wagner, J L Rutgers, et al.
Clinical Genetics
|
March 23, 2004
Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers
M Christiansen, S O Larsen, C Oxvig, et al.
The American Review of Respiratory Disease
|
December 1, 1991
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators
J B Sedgwick, W J Calhoun, G J Gleich, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis
K Yamazaki, K Suzuki, A Nakamura, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 1, 1996
Cytokine production at the site of disease in chronic eosinophilic pneumonitis
H Kita, S Sur, L W Hunt, et al.
Allergy
|
November 1, 1995
Allergen challenge in asthma: association of eosinophils and lymphocytes with interleukin-5
S Sur, G J Gleich, K P Offord, et al.
The American Review of Respiratory Disease
|
March 1, 1993
Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation
D S Collins, R Dupuis, G J Gleich, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 2, 1998
Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation
D Stelts, R W Egan, A Falcone, et al.
The Journal of Allergy and Clinical Immunology
|
September 13, 2000
Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected
H Kita, R K Jorgensen, C E Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1995
Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration
J A Sosman, K Bartemes, K P Offord, et al.
Page
of 49